Drug-drug Interactions and Safety Among JP-1366, Amoxicillin, and Clarithromycin in Healthy Volunteers

Exclusion criteria

• ✕. The Subject who has clinically significant diseases with liver, kidney, nervous system, digestive system, respiratory system, and endocrine system, musculoskeletal system or the blood or tumor disease, cardiovascular disease (including orthostatic hypotension), mental disorder or with history of the disease.
• ✕. The subject who has a history of gastrointestinal disorders (gastrointestinal ulcers, gastritis, gastric ulcer, gastroesophageal reflux disease, Crohn's disease, etc.) or history of gastrointestinal surgery that may affect the safety and PK/PD Evaluation of the investigational product (Except for simple cecal surgery and hernia surgery)
• ✕. The subject who has a hereditary disorder (galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption etc.).
• ✕. The subject with clinically significant hypersensitivity reactions (Except a slight allergic rhinitis which is no need to administration).
• ✕. The subject with the history of hypersensitivity reactions to the investigational product, the ingredients in investigational product (FCF, Sunset Yellow FCF), Digestive ulcer drugs and other drugs (aspirin, antibiotics, etc.)
• ✕. The subject who has a history of drug abuse or who has tested positive for an abuse drug in a drug screening test.
• ✕. Vital Sign Measures of resting blood pressure while the subject remained in the sitting position for at least 3 minutes. Systolic \> 150 mmHg or \< 90 mmHg, or diastolic \> 100 mmHg or \< 50 mmHg.
• ✕. Screening laboratory test showing any of the following abnormal laboratory results: